Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription


2 Arch Virol
1 J Infect
2 Lancet
1 Lancet Respir Med
2 PLoS One
4 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Arch Virol

  1. HASHEM AM, Azhar EI, Shalhoub S, Abujamel TS, et al
    Genetic characterization and diversity of circulating influenza A/H1N1pdm09 viruses isolated in Jeddah, Saudi Arabia between 2014 and 2015.
    Arch Virol. 2018 Feb 2. pii: 10.1007/s00705-018-3732.
    PubMed     Text format     Abstract available

  2. TSUNEKUNI R, Yaguchi Y, Kashima Y, Yamashita K, et al
    Spatial transmission of H5N6 highly pathogenic avian influenza viruses among wild birds in Ibaraki Prefecture, Japan, 2016-2017.
    Arch Virol. 2018 Feb 1. pii: 10.1007/s00705-018-3752.
    PubMed     Text format     Abstract available

    J Infect

  3. TENG Y, Bi D, Guo X, Hu D, et al
    Contact reductions from live poultry market closures limit the epidemic of human infections with H7N9 influenza.
    J Infect. 2018 Jan 31. pii: S0163-4453(18)30023.
    PubMed     Text format     Abstract available


  4. PAULES CI, Subbarao K
    Influenza vaccination and prevention of cardiovascular disease mortality - Authors' reply.
    Lancet. 2018;391:427-428.
    PubMed     Text format    

  5. CALDEIRA D, Ferreira JJ, Costa J
    Influenza vaccination and prevention of cardiovascular disease mortality.
    Lancet. 2018;391:426-427.
    PubMed     Text format    

    Lancet Respir Med

    App to model pandemic influenza.
    Lancet Respir Med. 2018;6:17-18.
    PubMed     Text format    

    PLoS One

  7. GONZALEZ-PARRA G, De Ridder F, Huntjens D, Roymans D, et al
    A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time.
    PLoS One. 2018;13:e0192645.
    PubMed     Text format     Abstract available

  8. SASAKI E, Momose H, Hiradate Y, Furuhata K, et al
    Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.
    PLoS One. 2018;13:e0191896.
    PubMed     Text format     Abstract available


  9. WESTCOTT MM, Clemens EA, Holbrook BC, King SB, et al
    The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells.
    Vaccine. 2018;36:1174-1182.
    PubMed     Text format     Abstract available

  10. KING JP, McLean HQ, Meece JK, Levine MZ, et al
    Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    Vaccine. 2018;36:1214-1219.
    PubMed     Text format     Abstract available

  11. WHITE KM, Ayllon J, Mena I, Potenski A, et al
    Influenza B virus reverse genetic backbones with improved growth properties in the EB66(R) cell line as basis for vaccine seed virus generation.
    Vaccine. 2018;36:1146-1153.
    PubMed     Text format     Abstract available

  12. RUSSELL K, Chung JR, Monto AS, Martin ET, et al
    Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
    Vaccine. 2018 Feb 2. pii: S0264-410X(18)30094.
    PubMed     Text format     Abstract available

    Virus Res

  13. KALENIK BM, Gora-Sochacka A, Sirko A
    Beta-defensins - Underestimated peptides in influenza combat.
    Virus Res. 2018;247:10-14.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.